Extremities Prospective Episealer® Talus clinical study fully recruited byJosh SandbergSeptember 13, 2023
Recon Regulatory Episurf Medical receives FDA 510(k) clearance for Episealer® Patellofemoral System byChris StewartDecember 27, 2022
Recon Regulatory Episealer® Patellofemoral System – planned 510(k) submission in Q4 2021 byChris StewartFebruary 19, 2021
Recon Positive results from follow-up of 30 patients in a Swedish multicentre clinical trial of the Episealer® Knee implant byChris StewartMarch 10, 2020
Hospitals Episurf Medical has received initial feedback from the US FDA on the IDE application for the Episealer® knee implant byJosh SandbergJuly 31, 2018
Extremities Episurf Medical in the final stages of development of an ankle implant byJosh SandbergFebruary 15, 2018
